143 related articles for article (PubMed ID: 3910595)
21. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.
Travers PJ; Arklie JL; Trowsdale J; Patillo RA; Bodmer WF
Natl Cancer Inst Monogr; 1982; 60():175-80. PubMed ID: 6181407
[TBL] [Abstract][Full Text] [Related]
22. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
23. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
25. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
[TBL] [Abstract][Full Text] [Related]
26. [Expression of HLA-class I and II antigens on basal cell carcinoma].
Nakamura T; Kageshita T; Hirai S; Kimura T; Yoshii A; Ono T; Arao T
Nihon Hifuka Gakkai Zasshi; 1990 Dec; 100(14):1431-5. PubMed ID: 2082044
[TBL] [Abstract][Full Text] [Related]
27. Distribution of neu (c-erbB-2) protein in human skin.
Maguire HC; Jaworsky C; Cohen JA; Hellman M; Weiner DB; Greene MI
J Invest Dermatol; 1989 Jun; 92(6):786-90. PubMed ID: 2470827
[TBL] [Abstract][Full Text] [Related]
28. Expression of HLA-A, -B, and -C and beta 2-microglobulin antigens in human choriocarcinoma cell lines.
Trowsdale J; Travers P; Bodmer WF; Patillo RA
J Exp Med; 1980 Aug; 152(2 Pt 2):11s-17s. PubMed ID: 6157763
[TBL] [Abstract][Full Text] [Related]
29. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
[TBL] [Abstract][Full Text] [Related]
30. Interferon-gamma induces class I HLA and beta 2-microglobulin expression by human amnion cells.
Hunt JS; Wood GW
J Immunol; 1986 Jan; 136(2):364-7. PubMed ID: 3079784
[TBL] [Abstract][Full Text] [Related]
31. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of cytokeratins, involucrin, and blood group antigens in oral squamous cell carcinomas.
Toto PD; Nadimi H
Oral Surg Oral Med Oral Pathol; 1990 Jul; 70(1):75-80. PubMed ID: 1695342
[TBL] [Abstract][Full Text] [Related]
33. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
34. Antigenic differences and further perspectives on the differential diagnosis of skin tumors.
Tosca AD; Lehou J; Panagiotopoulos A; Varelzidis A; Stratigos J
J Dermatol; 1986 Oct; 13(5):366-71. PubMed ID: 2434542
[No Abstract] [Full Text] [Related]
35. Concanavalin-A binding sites, pemphigus antigens, and beta 2 microglobulin in epidermal hyperproliferation, premalignant and malignant lesions.
Mahrle G; Patyk H; Bolling R
Arch Dermatol Res; 1982; 274(1-2):85-92. PubMed ID: 6187299
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.
Zuk JA; Walker RA
J Pathol; 1987 Aug; 152(4):275-85. PubMed ID: 3312546
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
Rossen K; Hou-Jensen K; Werdelin O
Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
[TBL] [Abstract][Full Text] [Related]
38. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
39. Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.
Walter A; Barysch MJ; Behnke S; Dziunycz P; Schmid B; Ritter E; Gnjatic S; Kristiansen G; Moch H; Knuth A; Dummer R; van den Broek M
Clin Cancer Res; 2010 Jul; 16(14):3562-70. PubMed ID: 20519358
[TBL] [Abstract][Full Text] [Related]
40. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
